Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 121.5 GBX 4.29% Market Closed
Market Cap: 103m GBX

Wall Street
Price Targets

DXRX Price Targets Summary
Diaceutics PLC

Wall Street analysts forecast DXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXRX is 203.39 GBX with a low forecast of 181.8 GBX and a high forecast of 236.25 GBX.

Lowest
Price Target
181.8 GBX
50% Upside
Average
Price Target
203.39 GBX
67% Upside
Highest
Price Target
236.25 GBX
94% Upside
Diaceutics PLC Competitors:
Price Targets
688222
HitGen Inc
4% Downside
A
Agilent Technologies Inc
21% Upside
RVU
Ryvu Therapeutics SA
140% Upside
1SXP
SCHOTT Pharma AG & Co KgaA
18% Upside
QNTPF
XtalPi Holdings Ltd
78% Upside
IQV
IQVIA Holdings Inc
23% Upside
ERF
Eurofins Scientific SE
0% Upside
PIQ
Proteomics International Laboratories Ltd
4% Downside

Revenue
Forecast

Revenue Estimate
Diaceutics PLC

For the last 7 years the compound annual growth rate for Diaceutics PLC's revenue is 23%. The projected CAGR for the next 3 years is 22%.

23%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Diaceutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Diaceutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXRX's stock price target?
Price Target
203.39 GBX

According to Wall Street analysts, the average 1-year price target for DXRX is 203.39 GBX with a low forecast of 181.8 GBX and a high forecast of 236.25 GBX.

What is Diaceutics PLC's Revenue forecast?
Projected CAGR
22%

For the last 7 years the compound annual growth rate for Diaceutics PLC's revenue is 23%. The projected CAGR for the next 3 years is 22%.

Back to Top